These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid. Author: de Salamanca RE, Peña ML, Olmos A, Molina C, Ladero JM. Journal: Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189. Abstract: The treatment of porphyria cutanea tarda (PCT) with p-aminobenzoic acid (PABA) was suggested because PABA is capable of reversing the porphyrinogenic action of 3,5-dicarbethoxy-1,4-dihydrocollidine (DDC) in rats. Three patients with PCT were treated with 3 g of PABA daily during 6 and 12 months and the urinary and faecal porphyrin excretion were serially analyzed by solvent extraction techniques and by thin layer chromatography of their methyl esters. PABA treatment did not show any apparent effect on porphyrin excretion.[Abstract] [Full Text] [Related] [New Search]